Dickinson K E, Matsumoto H, Anderson W, Pruitt R E, Uemura N, Hirschowitz B I
Division of Gastroenterology, University Station, Birmingham, Alabama.
J Pharmacol Exp Ther. 1988 Sep;246(3):879-86.
The muscarinic receptors coupled to pepsinogen secretion on isolated frog esophageal peptic cells have been characterized using functional and radioligand binding techniques. N-[3H]methylscopolamine [( 3H]NMS) binding to intact cells was complex and indicative of a high affinity, low capacity site and a high capacity uptake site. Binding to the high capacity site was inhibited by atropine with high affinity (IC50, 3 nM) and by imipramine and propranolol with IC50 values of 70 and 270 nM, respectively. After inhibition of uptake by 30 microM propranolol, [3H]NMS bound to a single population of high affinity sites (KD, 125 +/- 16 pM), which exhibited binding site maximum of 2.1 fmol/10(6) cells, equivalent to 1260 sites/cell. Binding to these sites was reversible, stereoselective and inhibited by muscarinic receptor agonists with an order of potency: oxotremorine greater than acetylcholine greater than carbachol greater than bethanechol and by antagonists with an order of potency:atropine greater than 4-diphenylacetoxy-N-methylpiperidine methobromide greater than pirenzepine greater than AF-DX 116 (11-2[2-[[diethylamino) methyl]-1-piperidinyl]acetyl]-5, 11-dihydro-6H-pyrido[2,3-b][1,4]-benzodiazepine-6-one). Pepsinogen secretion was stimulated by the agonists with an order of potency: acetylcholine greater than or equal to carbachol greater than oxotremorine greater than bethanechol. Atropine, pirenzepine and AF-DX 116 competitively inhibited carbachol-stimulated pepsinogen secretion with pA2 values of 9.58, 7.37 and 6.68, respectively, which correlated with their log (inhibition constants) for receptor binding. By contrast, agonists with significant efficacy exhibited EC50 values which were 20 to 90 times lower than their inhibition constants for binding which suggests the possibility of "spare" muscarinic receptors. Our findings indicate that functional muscarinic receptors on peptic cells exhibit similar characteristics to the high affinity sites labeled by [3H]NMS.(ABSTRACT TRUNCATED AT 250 WORDS)
运用功能和放射性配体结合技术,对分离出的蛙食管消化细胞上与胃蛋白酶原分泌相关的毒蕈碱受体进行了特性研究。N-[³H]甲基东莨菪碱([³H]NMS)与完整细胞的结合情况较为复杂,显示出一个高亲和力、低容量位点以及一个高容量摄取位点。与高容量位点的结合可被阿托品以高亲和力(IC50为3 nM)抑制,也可被丙咪嗪和普萘洛尔抑制,其IC50值分别为70 nM和270 nM。在用30 μM普萘洛尔抑制摄取后,[³H]NMS与单一群体的高亲和力位点结合(KD为125±16 pM),该位点的结合位点最大值为2.1 fmol/10⁶个细胞,相当于每个细胞1260个位点。与这些位点的结合是可逆的、立体选择性的,且可被毒蕈碱受体激动剂以如下效力顺序抑制:震颤素大于乙酰胆碱大于卡巴胆碱大于氨甲酰甲胆碱,也可被拮抗剂以如下效力顺序抑制:阿托品大于4-二苯基乙酰氧基-N-甲基哌啶甲基溴化物大于哌仑西平大于AF-DX 116(11-2[2-[[二乙氨基)甲基]-1-哌啶基]乙酰基]-5,11-二氢-6H-吡啶并[2,3-b][1,4]-苯并二氮杂䓬-6-酮)。胃蛋白酶原分泌受激动剂刺激的效力顺序为:乙酰胆碱大于或等于卡巴胆碱大于震颤素大于氨甲酰甲胆碱。阿托品、哌仑西平和AF-DX 116竞争性抑制卡巴胆碱刺激的胃蛋白酶原分泌,其pA2值分别为9.58、7.37和6.68,这与其受体结合的对数(抑制常数)相关。相比之下,具有显著效力的激动剂表现出的EC50值比其结合抑制常数低20至90倍,这表明存在“备用”毒蕈碱受体的可能性。我们的研究结果表明,消化细胞上的功能性毒蕈碱受体与[³H]NMS标记的高亲和力位点具有相似的特性。(摘要截断于250字)